Chakrabarti S - Search Results

1

Oxidative-stress-induced epigenetic changes in chronic diabetic complications.

Feng B, Ruiz MA, Chakrabarti S. Feng B, et al. Among authors: chakrabarti s. Can J Physiol Pharmacol. 2013 Mar;91(3):213-20. doi: 10.1139/cjpp-2012-0251. Epub 2012 Dec 17. Can J Physiol Pharmacol. 2013. PMID: 23537434 Review.

2

Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications.

Chakrabarti S, Khan ZA, Cukiernik M, Fukuda G, Chen S, Mukherjee S. Chakrabarti S, et al. Int J Exp Diabetes Res. 2002 Oct-Dec;3(4):217-31. doi: 10.1080/15604280214939. Int J Exp Diabetes Res. 2002. PMID: 12546275 Free PMC article. Review.

3

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications.

Chen S, Khan ZA, Cukiernik M, Chakrabarti S. Chen S, et al. Among authors: chakrabarti s. Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1089-97. doi: 10.1152/ajpendo.00540.2002. Epub 2003 Feb 11. Am J Physiol Endocrinol Metab. 2003. PMID: 12582013 Free article.

4

Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation.

Gan XT, Chakrabarti S, Karmazyn M. Gan XT, et al. Among authors: chakrabarti s. Can J Physiol Pharmacol. 2003 Feb;81(2):105-13. doi: 10.1139/y03-030. Can J Physiol Pharmacol. 2003. PMID: 12710522

5

Endothelins in chronic diabetic complications.

Khan ZA, Chakrabarti S. Khan ZA, et al. Among authors: chakrabarti s. Can J Physiol Pharmacol. 2003 Jun;81(6):622-34. doi: 10.1139/y03-053. Can J Physiol Pharmacol. 2003. PMID: 12839273 Review.

6

Heme oxygenase in diabetes-induced oxidative stress in the heart.

Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, Chakrabarti S. Farhangkhoee H, et al. Among authors: chakrabarti s. J Mol Cell Cardiol. 2003 Dec;35(12):1439-48. doi: 10.1016/j.yjmcc.2003.09.007. J Mol Cell Cardiol. 2003. PMID: 14654370

7

Heme-oxygenase-mediated iron accumulation in the liver.

Khan ZA, Barbin YP, Cukiernik M, Adams PC, Chakrabarti S. Khan ZA, et al. Among authors: chakrabarti s. Can J Physiol Pharmacol. 2004 Jul;82(7):448-56. doi: 10.1139/y04-052. Can J Physiol Pharmacol. 2004. PMID: 15389291

8

Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction.

Farhangkhoee H, Khan ZA, Barbin Y, Chakrabarti S. Farhangkhoee H, et al. Among authors: chakrabarti s. Diabetologia. 2005 Jul;48(7):1401-10. doi: 10.1007/s00125-005-1801-8. Epub 2005 May 25. Diabetologia. 2005. PMID: 15915335

9

Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.

Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S. Farhangkhoee H, et al. Among authors: chakrabarti s. Pharmacol Ther. 2006 Aug;111(2):384-99. doi: 10.1016/j.pharmthera.2005.10.008. Epub 2005 Dec 15. Pharmacol Ther. 2006. PMID: 16343639 Review.

10

Towards newer molecular targets for chronic diabetic complications.

Khan ZA, Farhangkhoee H, Chakrabarti S. Khan ZA, et al. Among authors: chakrabarti s. Curr Vasc Pharmacol. 2006 Jan;4(1):45-57. doi: 10.2174/157016106775203081. Curr Vasc Pharmacol. 2006. PMID: 16472176 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,234 results

Search Page